Table 3:
Total | Men | Women | |||||
---|---|---|---|---|---|---|---|
Median years at risk | Cancers (N=1575) | Cancers (N=883) | Cancers (N=692) | ||||
n | %* | n | %* | n | %* | ||
Common cancer sites | |||||||
Prostate | 2.08 | 207 | 13.1 | 207 | 23.4 | NA | NA |
Pancreas | 2.64 | 39 | 2.5 | 24 | 2.7 | 15 | 2.2 |
Melanoma | 2.21 | 129 | 8.2 | 87 | 9.9 | 42 | 6.1 |
Lung and bronchus | 2.54 | 115 | 7.3 | 60 | 6.8 | 55 | 8.0 |
Kidney | 1.34 | 100 | 6.4 | 67 | 7.6 | 33 | 4.8 |
Female breast | 2.88 | 227 | 14.5 | NA | NA | 227 | 32.8 |
Corpus uteri | 1.40 | 84 | 5.3 | NA | NA | 84 | 12.1 |
Colorectal | 2.47 | 78 | 5.0 | 46 | 5.2 | 32 | 4.6 |
Cancer stage | |||||||
In Situ | 2.28 | 178 | 11.3 | 86 | 9.8 | 92 | 13.3 |
Localized | 2.06 | 788 | 51.0 | 451 | 51.1 | 337 | 48.6 |
regional | 2.01 | 265 | 16.8 | 134 | 15.2 | 131 | 18.9 |
Metastatic | 2.28 | 292 | 18.5 | 179 | 20.3 | 113 | 16.3 |
Percent’s for cancer site do not sum to 100% because less commonly diagnosed cancer sites are not listed or missing stage information